Shire hires global therapeutics head
Executive Summary
Shire Pharmaceuticals names Michael Cola as exec VP of global therapeutics area business units. Cola joins Shire on July 1 from Safeguard Scientifics where he was life sciences division president; Cola will report to Shire CEO Matt Emmens. Cola will lead Shire's therapeutic teams, created in 2004, to ensure effective management of existing products and identification of new products for the pipeline...